Suppr超能文献

[慢性阻塞性肺疾病严重急性加重患者的抗菌治疗]

[Antimicrobial treatment of patients with severe acute exacerbation of COPD].

作者信息

Klapdor B, Ewig S

机构信息

Thoraxzentrum Ruhrgebiet, Kliniken für Pneumologie und Infektiologie, EVK Herne und Augusta-Krankenanstalt Bochum, Bergstr. 26, 44791, Bochum, Deutschland.

出版信息

Med Klin Intensivmed Notfmed. 2012 Apr;107(3):179-84. doi: 10.1007/s00063-011-0066-x. Epub 2012 Mar 22.

Abstract

Chronic obstructive lung disease (COPD) is a leading cause of death worldwide. In patients with acute exacerbations admitted to an intensive care unit (ICU), potentially pathogenic microorganisms can be found in approximately 50%, with Haemophilus influenzae and Streptococcus pneumoniae as the leading strains, followed by enterobacteria and Pseudomonas aeruginosa. Viruses can also be detected in a large proportion of patients. The indication for antimicrobial treatment of acutely exacerbated COPD is still controversial but recommended by guidelines for all patients admitted to an ICU. Appropriate agents for an empiric initial treatment are penicillins + betalactamase inhibitor, 2(nd) and 3(rd) generation cephalosporins, carbapenems, and quinolones. Antimicrobial treatment should be adjusted according to the results of microbial investigation of sputum or endotracheal aspirate.

摘要

慢性阻塞性肺疾病(COPD)是全球主要的死亡原因之一。在入住重症监护病房(ICU)的急性加重患者中,约50%可发现潜在致病微生物,其中流感嗜血杆菌和肺炎链球菌是主要菌株,其次是肠杆菌和铜绿假单胞菌。在很大一部分患者中也可检测到病毒。COPD急性加重期抗菌治疗的指征仍存在争议,但指南建议对所有入住ICU的患者进行抗菌治疗。经验性初始治疗的合适药物包括青霉素+β-内酰胺酶抑制剂、第二代和第三代头孢菌素、碳青霉烯类和喹诺酮类。应根据痰或气管内吸出物的微生物检测结果调整抗菌治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验